Articles by Disease (Myeloma, Multiple)

An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs

Journal: Current Topics in Medicinal Chemistry
Volume: 16
Page: 2156-2168
Author(s): Deepak Bhattarai, Sarbijt Singh, Yerin Jang, Seung Hyeon Han, Kyeong Lee and Yongseok Choi

Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component

Journal: Current Bioactive Compounds
Volume: 12
Page: 3-9
Author(s): Agostino Casapullo, Federica Del Gaudio, Angela Capolupo, Chiara Cassiano and Maria Chiara Monti

Sphingosine Kinases Signalling in Carcinogenesis

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15
Page: 300-314
Author(s): Gabriella Marfe, Giovanna Mirone, Arvind Shukla and Carla Di Stefano

MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies

Journal: Current Cancer Drug Targets
Volume: 15
Page: 53-70
Author(s): Xin Li, Xin A. Zhang, Wei Xie, Xiaoqing Li and Shiang Huang

Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma

Journal: Current Cancer Therapy Reviews
Volume: 10
Page: 70-79
Author(s): Giada Bianchi and Irene M. Ghobrial

IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma

Journal: Current Medicinal Chemistry
Volume: 21
Page: 3042-3047
Author(s): I. Kolosenko, D. Grander and K.P. Tamm

Circulating Levels of Soluble Angiogenic Factors in Multiple Myeloma: Correlation with Parameters of Disease Activity and Prognosis

Journal: Current Angiogenesis (Discontinued)
Volume: 2
Page: 76-95
Author(s): Michael G. Alexandrakis and George Tsirakis